Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, Covid case numbers have continued to rise across the UK in record numbers, ...
Liverpool has seen high numbers of coronavirus cases in recent weeks, and the Government is now trialling a new testing pilot in the region. Residents and those who work in Liverpool are being offered ...
Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...
UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...
After over two years, we're finally seeing a return to somewhat of a 'normal' life in a post-pandemic world, with the government recently announcing its plans for how we'll be "living with COVID-19".
Just as we thought we understood COVID testing, along came omicron and raised a whole new bunch of questions. We asked Dr Andrew Lee, a reader in global public health, to answer them. The UK ...
Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...
Vaccinated travellers entering England from abroad will be able to take a day two lateral flow test instead of a more expensive PCR test from Sunday 24 October, in a move by the UK Government to make ...
The UK government recently asked all secondary schools to provide on-site COVID-19 testing for pupils, and advised secondary, college and university students to continue twice weekly testing, in an ...
An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. In work published in Cell Reports Medicine, a team of researchers from the ...
The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...
CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...